Novozymes acquires Iogen Bio-Products from Iogen - MarketLine Financial Deals

Novozymes acquires Iogen Bio-Products from Iogen

Novozymes acquires Iogen Bio-Products from Iogen - MarketLine Financial Deals
Novozymes acquires Iogen Bio-Products from Iogen
Published Feb 22, 2013
3 pages — Published Feb 22, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Novozymes A/S, a Denmark-based an enzyme biotech company focused on discovery, manufacturing, and marketing of industrial enzymes, has acquired Iogen Bio-Products.

  
Source:
Document ID
MA137638_130301
Country
Country
Ticker
NZYM B=DK
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Novozymes acquires Iogen Bio-Products from Iogen" Feb 22, 2013. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novozymes-acquires-Iogen-Bio-Products-from-Iogen-2052-93239>
  
APA:
MarketLine Financial Deals. (2013). Novozymes acquires Iogen Bio-Products from Iogen Feb 22, 2013. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novozymes-acquires-Iogen-Bio-Products-from-Iogen-2052-93239>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.